Market Research Logo

European Market Report for Nephrostomy Devices 2016 - MedCore

European Market Report for Nephrostomy Devices 2016 - MedCore

This report categorizes one unit of a percutaneous nephrostomy set as all the necessary devices required to gain access in order to establish a nephrostomy tract and place a nephrostomy tube or ureteral stent. The choice of access system depends on which guidance method (ultrasonography, conventional fluoroscopy or CT) is employed. In general, a percutaneous nephrostomy set includes one or two puncture needles, guidewires, introducing catheters, cannulas and dilators. Nephrostomy balloon catheters are used to establish nephrostomy tracts and can come in kits which include the dilation system, balloons, port grips, sheath locks, inflation ports and sheaths. The market for nephrostomy devices includes percutaneous nephrostomy sets, nephrostomy balloon catheters, and nephrostomy drainage tubes. Although devices can be purchased as part of sets/kits, they are also sold individually.

Under normal circumstances urine travels between the kidneys and bladder through the ureters. When a blockage prevents this flow, ureteral stents are usually threaded into the ureter as a solution. In cases where this is not the best option, a nephrostomy tube can be used to maintain a passageway between the skin and renal pelvis to facilitate drainage. Without treatment, pressure would build within the urinary system and cause kidney damage. Blockage can result from tumors, kidney stones and pyonephrosis or the infection of the renal pelvis and collecting system.


LIST OF FIGURES
LIST OF CHARTS
EXECUTIVE SUMMARY
EUROPEAN UROLOGICAL DEVICE MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
MARKETS INCLUDED
PROCEDURES INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.1.1 Human Urinary System
2.2 URINARY PATHOLOGY AND DISORDERS
2.2.1 Benign Prostate Hyperplasia (BPH)
2.2.2 Urinary Incontinence
2.2.3 Urinary Tract Infections (UTI)
2.2.4 Kidney Stones
2.2.5 Bladder Prolapse
2.2.6 Overactive Bladder
2.2.7 Prostatitis
2.2.8 Erectile Dysfunction (ED)
2.2.9 Cancer
2.2.9.1.1 Prostate Cancer
2.2.9.1.2 Bladder Cancer
2.3 PATIENT DEMOGRAPHICS
2.3.1 Benign Prostatic Hyperplasia
2.3.2 Urinary Incontinence
2.3.3 UTI
2.3.4 Kidney Stones
2.3.5 Erectile Dysfunction
2.3.6 Overactive Bladder
2.3.7 Prostatitis
2.3.8 Cancer
2.3.8.1 Prostate Cancer
2.3.8.2 Bladder Cancer
PRODUCT ASSESSMENT
3.1 PRODUCT PORTFOLIOS
3.1.1 Nephrostomy
3.2 CLINICAL TRIALS
3.2.1 Boston Scientific
3.2.2 C.R. Bard
3.2.3 Coloplast
3.2.4 Dornier MedTech
3.2.5 Ethicon
3.2.6 GE (Oncura)
3.2.7 Hollister
3.2.8 Lumenis
3.2.9 Olympus
3.2.10 Teleflex
3.2.11 WellSpect Healthcare
COUNTRY PROFILES
4.1 INTRODUCTION
4.1.1.1 Population
4.1.1.2 Median Age
4.1.1.3 GDP Per Capita
4.1.1.4 Price Index
4.2 GERMANY
4.3 FRANCE
4.4 UNITED KINGDOM
4.5 ITALY
4.6 SPAIN
4.7 BENELUX
4.8 SCANDINAVIA
4.9 AUSTRIA
4.10 SWITZERLAND
4.11 PORTUGAL
NEPHROSTOMY DEVICE MARKET
5.1 INTRODUCTION
5.2 MARKET OVERVIEW
5.3 MARKET ANALYSIS AND FORECAST
5.3.1 Total Nephrostomy Device Market
5.3.2 Percutaneous Nephrostomy Access Market
5.3.3 Balloon Dilator Market
5.3.4 Nephrostomy Tube Market
5.4 DRIVERS AND LIMITERS
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
APPENDIX II: COMPANY PRESS RELEASES
List of Charts
Chart 1 1: Total Urological Device Market, Europe, 2012 – 2022
Chart 1 2: Total Urological Device Market Overview, Europe, 2015 & 2022
Chart 4 1: Country Profile, Germany, 2015
Chart 4 2: Country Profile, France, 2015
Chart 4 3: Country Profile, United Kingdom, 2015
Chart 4 4: Country Profile, Italy, 2015
Chart 4 5: Country Profile, Spain, 2015
Chart 4 6: Country Profile, Benelux, 2015
Chart 4 7: Country Profile, Scandinavia, 2015
Chart 4 8: Country Profile, Austria, 2015
Chart 4 9: Country Profile, Switzerland, 2015
Chart 4 10: Country Profile, Portugal, 2015
Chart 5 1: Nephrostomy Device Market by Segment, Europe, 2012 – 2022
Chart 5 2: Nephrostomy Device Market by Segment, Europe, 2015
Chart 5 3: Nephrostomy Device Market by Segment, Europe, 2022
Chart 5 4: Total Nephrostomy Device Market, Europe, 2012 – 2022
Chart 5 5: Percutaneous Nephrostomy Access Market, Europe, 2012 – 2022
Chart 5 6 Balloon Dilator Market, Europe, 2012 – 2022
Chart 5 7: Nephrostomy Tube Market, Europe, 2012 – 2022
Chart 5 8: Leading Competitors, Nephrostomy Market, Europe, 2015
List of Figures
Figure 1 1: Urological Device Competitor Market Share Ranking by Segment, Europe, 2015 (1 of 2)
Figure 1 2: Urological Device Competitor Market Share Ranking by Segment, Europe, 2015 (2 of 2)
Figure 1 3: Companies Mentioned in Report
Figure 1 4: Factors Impacting the Urological Device Market by Segment, Europe (1 of 2)
Figure 1 5: Factors Impacting the Urological Device Market by Segment, Europe (2 of 2)
Figure 1 6: Recent Events in Urological Device Market, Europe, 2012 – 2016
Figure 1 7: Urological Device Markets Covered, Europe, 2015, (Part 1 of 2)
Figure 1 8: Urological Device Markets Covered, Europe, 2015, (Part 2 of 2)
Figure 1 9: Urological Procedures Covered, Europe, 2015
Figure 1 10: Key Report Updates
Figure 1 11: Version History
Figure 3 1: Nephrostomy Products by Company
Figure 3 2: Safety and Effectiveness of Jetstream Atherectomy System (J-SUPREME)
Figure 3 3: Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology (PINNACLE FLX)
Figure 3 4: Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy (MIRACLEIII)
Figure 3 5: Watchman FLX Left Atrial Appendage Closure Device Post Approval Study
Figure 3 6: Expanding MRI Access for Patients With New and Existing ICDs and CRT-Ds ( ENABLE MRI) (ENABLE MRI)
Figure 3 7: Observation of ImageReady™ MR Conditional Pacing System in China
Figure 3 8: EVOLVE Short DAPT Study
Figure 3 9: ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent (IMPERIAL)
Figure 3 10: CoverEdge Algorithm Programming Study
Figure 3 11: Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement
Figure 3 12: The Captivator EMR Registry
Figure 3 13: FAST Feasibility Study
Figure 3 14: Using the Vessix Renal Denervation System for the Treatment of Hypertension
Figure 3 15: A Study to Evaluate the Effect of Precision Spectra™ Programming
Figure 3 16: Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft
Figure 3 17: Study of Phasix™ Mesh for VHWG Grade 3 Midline Hernia Repair
Figure 3 18: A Single Arm Trial Evaluating the BARD Lutonix Drug-Coated Balloon
Figure 3 19: Korean Post-market Registry Assessing the Clinical Use and Safety of the Lutonix
Figure 3 20: A Prospective Trial of a Bio-absorbable Mesh
Figure 3 21: A Post-Market, Single-Arm Trial of XenMatrix™ AB Surgical Graft
Figure 3 22: BARD® The VENOVO™ Venous Stent Study
Figure 3 23: Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft (AVeNEW)
Figure 3 24: Time and Motion Related to PICC Insertion Process and Catheter Tip Confirmation
Figure 3 25: Prospective Feasibility Trial of AccuCath 2.25 BC
Figure 3 26: Study Comparing Lutonix AV Drug Coated Balloon vs Standard Balloon for Treatment
Figure 3 27: Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
Figure 3 28: Investigation of Two New 1-piece Ostomy Products
Figure 3 29: Investigation of a New 2-piece Ostomy Product
Figure 3 30: Altis® 522 Trial - Treatment of Female Stress Urinary Incontinence
Figure 3 31: ARIES for Vasculogenic Erectile Dysfunction
Figure 3 32: The EVICEL® Neurosurgery Phase III Study
Figure 3 33: Powered Surgical Stapler in VATS Lung Resection Procedures in China
Figure 3 34: Development of a MR Scanner Capable of Being Sited in a Neonatal Intensive Care Unit
Figure 3 35: Clinical Evaluation of a Dual Energy CT System
Figure 3 36: Assessment of a Oral Endotracheal Tube Fastener
Figure 3 37: Utilizing Holmium Laser for FURS Renal Stone Lithotripsy
Figure 3 38: Ablation Efficacy of Contact Side Firing Fiber in Predefined Settings for Treating BPH.
Figure 3 39: Feasibility of IPL for Reducing Dry Eye Symptoms Caused by MGD
Figure 3 40: Radiofrequency Ablation for Multi-level Obstructive Sleep Apnea
Figure 3 41: Evaluation and Control of WAG in PACU Within Patient and Caregiver Breathing Zone
Figure 3 42: Evaluation of a Novel Electronic Transanal Irrigation System - Navina™ Smart
Figure 5 1: Nephrostomy Device Market by Segment, Europe, 2012 – 2022 (€M)
Figure 5 2: Nephrostomy Device Market by Segment, Europe, 2012 – 2022 (US$M)
Figure 5 3: Total Nephrostomy Device Market, Europe, 2012 – 2022 (€ and US$)
Figure 5 4: Units Sold by Country, Total Nephrostomy Market, Europe, 2012 – 2022
Figure 5 5: Average Selling Price by Country, Total Nephrostomy Market, Europe, 2012 – 2022 (€)
Figure 5 6: Average Selling Price by Country, Total Nephrostomy Market, Europe, 2012 – 2022 (US$)
Figure 5 7: Market Value by Country, Total Nephrostomy Market, Europe, 2012 – 2022 (€M)
Figure 5 8: Market Value by Country, Total Nephrostomy Market, Europe, 2012 – 2022 (US$M)
Figure 5 9: Percutaneous Nephrostomy Access Market, Europe, 2012 – 2022 (€ and US$)
Figure 5 10: Units Sold by Country, Percutaneous Nephrostomy Access Market, Europe, 2012 – 2022
Figure 5 11: Average Selling Price by Country, Percutaneous Nephrostomy Access Market, Europe, 2012 – 2022 (€)
Figure 5 12: Average Selling Price by Country, Percutaneous Nephrostomy Access Market, Europe, 2012 – 2022 (US$)
Figure 5 13: Market Value by Country, Percutaneous Nephrostomy Access Market, Europe, 2012 – 2022 (€M)
Figure 5 14: Market Value by Country, Percutaneous Nephrostomy Access Market, Europe, 2012 – 2022 (US$M)
Figure 5 15: Balloon Dilator Market, Europe, 2012 – 2022 (€ and US$)
Figure 5 16: Units Sold by Country, Balloon Dilator Market, Europe, 2012 – 2022
Figure 5 17: Average Selling Price by Country, Balloon Dilator Market, Europe, 2012 – 2022 (€)
Figure 5 18: Average Selling Price by Country, Balloon Dilator Market, Europe, 2012 – 2022 (US$)
Figure 5 19: Market Value by Country, Balloon Dilator Market, Europe, 2012 – 2022 (€M)
Figure 5 20: Market Value by Country, Balloon Dilator Market, Europe, 2012 – 2022 (US$M)
Figure 5 21: Nephrostomy Tube Market, Europe, 2012 – 2022 (€ and US$)
Figure 5 22: Units Sold by Country, Nephrostomy Tube Market, Europe, 2012 – 2022
Figure 5 23: Average Selling Price by Country, Nephrostomy Tube Market, Europe, 2012 – 2022 (€)
Figure 5 24: Average Selling Price by Country, Nephrostomy Tube Market, Europe, 2012 – 2022 (US$)
Figure 5 25: Market Value by Country, Nephrostomy Tube Market, Europe, 2012 – 2022 (€M)
Figure 5 26: Market Value by Country, Nephrostomy Tube Market, Europe, 2012 – 2022 (US$M)
Figure 5 27: Drivers and Limiters, Nephrostomy Market, Europe, 2015
Figure 5 28: Leading Competitors, Nephrostomy Market, Europe, 2015
Figure 7 1: Press Release Summary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report